New impurities requirements cause confusion; FDA issues fewer warning letters

> Domestic drugmakers in Pakistan have launched nearly 3,000 new products from 2008 to 2012, according to the head of the Pakistan Pharmaceutical Manufacturers Association. Report

> Drug manufacturers are confused by looming new requirements for testing impurities in pharmaceuticals and excipients. Story

> Pagemark Technology has released a new track-and-trace product that embeds a covert layer into 2D barcodes that can help protect against counterfeiting. Release

> India's decision to invalidate a Novartis ($NVS) patent has landed the country back on the U.S. watch list for intellectual property concerns. Story

And Finally... The FDA has been issuing fewer warning letters in the past couple of years. Blog post